Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board
Saved in:
| Title: | Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board |
|---|---|
| Authors: | National Comprehensive Cancer Network |
| Source: | Business Wire (English). 08/09/2012. |
| Abstract: | The NCCN Foundation, which through private philanthropy and grants advances the mission of the National Comprehensive Cancer Network® (NCCN®) to improve the quality and effectiveness of care for patients with cancer, welcomes Josh Bilenker, MD, Partner at Aisling Capital and former Medical Officer for the U.S. Food and Drug Administration (FDA), as the newest member of the Board of the NCCN Foundation. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The NCCN Foundation, which through private philanthropy and grants advances the mission of the National Comprehensive Cancer Network® (NCCN®) to improve the quality and effectiveness of care for patients with cancer, welcomes Josh Bilenker, MD, Partner at Aisling Capital and former Medical Officer for the U.S. Food and Drug Administration (FDA), as the newest member of the Board of the NCCN Foundation. [ABSTRACT FROM PUBLISHER] |
|---|
